NCT07870070 · ACTIVE NOT RECRUITING

Functionalized Point of Care and 3D Printed Dental Aligners as Devices for Early Detection of Neurodegenerative Diseases

This study looks for tiny molecules called microRNAs in saliva that differ in people with Alzheimer's compared with healthy people. Researchers also want to build a simple saliva sensor, possibly tied to dental aligners, to detect them. It is an early detection tool, not a treatment. No phase is listed, and no drug is being given.

You may qualify if

  • age >50 years
  • diagnosis: Alzheimer's disease

You're excluded if

  • age \<50 years

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-10-13

View full record on ClinicalTrials.gov

All APOE4 clinical trials